Request for Generic Risdiplam Accessibility Under Rare Disease Policy for…
Patients have submitted an appeal to the Prime Minister, emphasizing the urgent need for timely access to Risdiplam, a generic medication now manufactured in India. This treatment is crucial for individuals suffering from spinal muscular atrophy (SMA), a life-limiting neuromuscular
